The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 10, 2005, Pages 3790-3794

  Cruysberg, Lars P J ^b   Nuijts, Rudy M M A ^b   Geroski, Dayle H ^b   Gilbert, Jake A ^b   Hendrikse, Fred ^b   Edelhauser, Henry F ^a  

^a EMORY EYE CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; BOVINE SERUM ALBUMIN; DEXTRAN; DRUG DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE; FLUORESCEIN ISOTHIOCYANATE BOVINE SERUM ALBUMIN;

ARTICLE; CELL MEMBRANE PERMEABILITY; CHOROID; CONTROLLED STUDY; DIFFUSION; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE; MOLECULAR WEIGHT; PRIORITY JOURNAL; SCLERA; SPECTROFLUOROMETRY; DIFFUSION CHAMBER; METABOLISM; MIDDLE AGED; PERMEABILITY; PHYSIOLOGY;

DEXTRANS; DIFFUSION; DIFFUSION CHAMBERS, CULTURE; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; MOLECULAR WEIGHT; PERMEABILITY; SCLERA; SERUM ALBUMIN, BOVINE; SPECTROMETRY, FLUORESCENCE;

EID: 32944479596     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-1414     Document Type: Article

References (31)

1. Geroski DH, Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci. 2000;41:961-964.
2. Ambati J, Adamis AP. Transscleral drug delivery to the retina and choroid. Prog Retin Eye Res. 2002;21:145-151.
3. Rudnick DE, Noonan JS, Geroski DH, Prausnitz MR, Edelhauser HF. The effect of intraocular pressure on human and rabbit scleral permeability. Invest Ophthalmol Vis Sci. 1999;40:3054-3058.
4. Olsen TW, Edelhauser HF, Lim JI, Geroski DH. Human scleral permeability: effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Ophthalmol Vis Sci. 1995;36:1893-1903.
5. Ambati J, Canakis CS, Miller JMC, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41:1181-1185.
6. Barkana Y, Belkin M. Neuroprotection in ophthalmology: a review. Brain Res Bull. 2004;15;62:447-453.
7. Das A, McGuire PG. Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Prog Retin Eye Res. 2003;22:721-748.
8. Lang JC. Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev. 1995;16:39-43.
9. Schoenwald RD, Deshpande GS, Rethwisch DG, Barfknecht CF. Penetration into the anterior chamber via the conjunctival/scleral pathway. J Ocul Pharmacol. 1997;13:41-59.
10. Smelser GK, Ishikawa T, Pei YF. In: Rohen EW, ed. Structure of the Eye. Vol. II. Stuttgart Germany: Schattauer-Verlag; 1965:109-120.
11. Peyman GA, Bok D. Peroxidase diffusion in the normal and laser-coagulated primate retina. Invest Ophthalmol. 1972;11:35-45.
12. Marmor MF, Negi A, Maurice DM. Kinetics of macromolecules injected into the subretinal space. Exp Eye Res. 1985;40:687-696.
13. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. Am J Ophthalmol. 1999;128:739-746.
14. Kim TW, Lindsey JD, Aihara M, Anthony TL, Weinreb RN. Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice. Invest Ophthalmol Vis Sci. 2002;43:1809-1816.
15. Maurice DM, Polgar J. Diffusion across the sclera. Exp Eye Res. 1977;25:577-582.
16. Cruysberg LPJ, Nuijts RMMA, Geroski DH, Koole LH, Hendrikse F, Edelhauser HF. In vitro human scleral permeability of fluorescein, dexamethasone- fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system. J Ocul Pharmacol Ther. 2002;18:559-569.
17. Olsen TW, Sanderson S, Feng X, Hubbard WC. Porcine sclera: thickness and surface area. Invest Ophthalmol Vis Sci. 2002;43: 2529-2532.
18. Schroder U, Arfors KE, Tangen O. Stability of fluorescein labeled dextrans in vivo and in vitro. Microvasc Res. 1976;11:57-66.
19. Hämäläinen KM, Kananen K, Auriola S, Kontturi K, Urtti A. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Vis Sci. 1997;38:627-634.
20. Tao L, Nicholson C. Diffusion of albumins in rat cortical slices and relevance to volume transmission. Neuroscience. 1996;5:839-847.
21. Edwards A, Prausnitz MR. Fiber matrix model of sclera and corneal stroma for drug delivery to the eye. Am Inst Chem Eng AICHE J. 1998;44:214-225.
22. Cooper ER, Kasting G. Transport across epithelial membranes. J Control Rel. 1987;6:23-35.
23. Inomata H, Bill A. Exit sites of uveoscleral flow of aqueous humor in cynomolgus monkey eyes. Exp Eye Res. 1977;25:113-118.
24. Nicholson C, Tao L. Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging. Biophys J. 1993;65:2277-2290.
25. Olsen TW, Aaberg SY, Geroski DH, Edelhauser HF. Human sclera: thickness and surface area. Am J Ophthalmol. 1998;125:237-241.
26. Lee SB, Geroski DH, Prausnitz MR, Edelhauser HF. Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Exp Eye Res. 2004;78:599-607.
27. Kim H, Robinson MR, Lizak MJ, et al. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging. Invest Ophthalmol Vis Sci. 2004;45:2722-2734.
28. Pitkanen L, Ranta VP, Moilanen H, Urtti A. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci. 2005;46:641-646.
29. Ahmed I, Patton TF. Importance of the non-corneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci. 1985;26:584-587.
30. Ambati J, Gragoudas ES, Miller JW, et al. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci. 2000;41:1186-1191.
31. Simpson AE, Gilbert JA, Rudnick DE, Geroski DH, Aaberg TM Jr, Edelhauser HF. Transscleral diffusion of carboplatin: an in vitro and in vivo study. Arch Ophthalmol. 2002;20:1069-1074.